Spectrum Pharmaceuticals, Inc.
KITS AND METHODS FOR TREATING CANCERS
Last updated:
Abstract:
A kit containing a crystalline form of a quinazoline compound. More particularly, the crystalline form is derived from the compound of 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)pi- peridin-1-yl)prop-2-en-1-one. Also disclosed is a method of treating cancers with the crystalline form or a kit thereof.
Status:
Application
Type:
Utility
Filling date:
12 Sep 2019
Issue date:
10 Feb 2022